A Guide for the Preparation of Applications for Authorization of Positron=emitting Radiopharmaceuticlas for Use in Basic Clinical Research Studies | |||
---|---|---|---|
분류 | Radiopharmaceuticals, Clinical researh, Guidance | 조회 | 2377 |
발행년도 | 2014 | 등록일 | 2015-10-02 |
출처 | Health Canada (바로가기) | ||
This Guidance document provides information on the interpretation and application of sections C.03.301 to C.03.320 of the Food and Drug Regulations (the Regulations) applicable to positron-emitting radiopharmaceuticals (PERs) used in basic clinical research studies.
(후략)
|
|
이전글 | Safety in Magnetic Resonance Imaging |
---|---|
다음글 | Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [F-18]Fluorodeoxyglucose(FDG) |